Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Pilot Estimation Study to Compare the Safety and Efficacy of Raltegravir+TDF+3TC Versus TDF+3TC+EFV in HBV/HIV Co-infected Patients

NCT01318096 is registered in ClinicalTrials.gov with Yunnan AIDS Care Center as lead sponsor.

NCT NCT01318096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01318096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Pilot Estimation Study to Compare the Safety and Efficacy of Raltegravir+TDF+3TC Versus TDF+3TC+EFV in HBV/HIV Co-infected Patients
Lead sponsor
Yunnan AIDS Care Center
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2011
Completion date
September 30, 2013
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hbv coinfection, hiv infections